Literature DB >> 27891368

Is the Mean Platelet Volume a Predictive Marker of a Low Apgar Score and Insulin Resistance in Gestational Diabetes Mellitus? A Retrospective Case-Control Study.

Levent Kebapcilar1, Ayse Gul Kebapcilar2, Tolgay Tuyan Ilhan3, Suleyman Hilmi Ipekci1, Suleyman Baldane4, Aybike Pekin2, Mustafa Kulaksizoglu5, Cetin Celik6.   

Abstract

INTRODUCTION: Gestational diabetes is defined as various degrees of glucose intolerance diagnosed or detected for the first time during pregnancy and is the most common metabolic complication of pregnancy. Early diagnosis and adequate treatment are important to prevent complications. Pre-eclampsia, polyhydramnios, fetalmacrosomia, and operative delivery are some of the complications seen in pregnant women diagnosed with Gestational Diabetes Mellitus (GDM). AIM: The present study was designed to determine whether there was an association between Mean Platelet Volume (MPV) in predicting poor fetal outcome, insulin resistance, neonatal Apgar scores and gestational age for women with GDM.
MATERIALS AND METHODS: In this retrospective study, we enrolled 101 pregnant women with GDM together with a group of 138 healthy controls. MPV, insulin and homeostatic model assessment (HOMA-IR) values were measured at 24-28 weeks of the pregnancy. An independent samples t-test was used to compare MPV values. Multivariate linear regression models were used to establish relations between MPV values, HOMA-IR, insulin levels and Apgar score.
RESULTS: There was a significant positive correlation between MPV values, HOMA-IR and Insulin levels and a negative correlation with Apgar score at 1 min and 5 min in the GDM group (r=0.227, p=0.02; r=0.206, p=0.03; r=-0.485, p<0.001; and r=-0.399, p<0.001, respectively). In the multivariate logistic regression analysis, a high MPV value was most consistently associated with a low Apgar 1 min score (β=-0.387, p=0.003) in the GDM group. An MPV of >8.0 fL had a sensitivity of 82% and a specificity of 75% for the prediction of GDM.
CONCLUSION: We investigated the potential of MPV values in predicting low Apgar scores and insulin resistance in women with GDM.

Entities:  

Keywords:  Glucose intolerance; HOMA-IR index; Hyperglycaemia; Metabolic complication; Pregnancy

Year:  2016        PMID: 27891368      PMCID: PMC5121706          DOI: 10.7860/JCDR/2016/20874.8611

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  42 in total

Review 1.  Platelet function, coagulopathy, and impaired fibrinolysis in diabetes.

Authors:  Burton E Sobel; David J Schneider
Journal:  Cardiol Clin       Date:  2004-11       Impact factor: 2.213

2.  [Mean platelet volume in diabetics].

Authors:  K Saigo; M Yasunaga; R Ryo; N Yamaguchi
Journal:  Rinsho Byori       Date:  1992-02

3.  Increased platelet reactivity in pregnancy-induced hypertension and uncomplicated diabetic pregnancy: an indication for antiplatelet therapy?

Authors:  I A Greer; A A Calder; J J Walker; C B Lunan; I Tulloch
Journal:  Br J Obstet Gynaecol       Date:  1988-11

4.  Committee opinion no. 504: Screening and diagnosis of gestational diabetes mellitus.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-09       Impact factor: 7.661

Review 5.  Platelet sizing: techniques, biological significance, and clinical applications.

Authors:  L Corash
Journal:  Curr Top Hematol       Date:  1983

6.  Structural, functional and circulatory placental changes associated with impaired glucose metabolism.

Authors:  Pia Saldeen; Per Olofsson; Ricardo N Laurini
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2002-11-15       Impact factor: 2.435

7.  A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus.

Authors:  E Iwase; M Tawata; K Aida; Y Ozaki; S Kume; K Satoh; R Qi; T Onaya
Journal:  Metabolism       Date:  1998-06       Impact factor: 8.694

Review 8.  Neonatal morbidities in gestational diabetes mellitus.

Authors:  B Persson; U Hanson
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

Review 9.  Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research.

Authors:  Lisa Hartling; Donna M Dryden; Alyssa Guthrie; Melanie Muise; Ben Vandermeer; Lois Donovan
Journal:  Ann Intern Med       Date:  2013-07-16       Impact factor: 25.391

10.  Reduced umbilical artery prostacyclin formation in complicated pregnancies.

Authors:  C Dadak; A Kefalides; H Sinzinger; G Weber
Journal:  Am J Obstet Gynecol       Date:  1982-12-01       Impact factor: 8.661

View more
  4 in total

Review 1.  Mean Platelet Volume and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Zhongwei Zhou; Hongmei Chen; Mingzhong Sun; Huixiang Ju
Journal:  J Diabetes Res       Date:  2018-05-02       Impact factor: 4.011

2.  Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study.

Authors:  Benjamin S Umezuluike; Chidebe C Anikwe; Oluomachi C Nnachi; Bobbie C A Iwe; Chinedu C Ifemelumma; Ikechukwu B O Dimejesi
Journal:  Heliyon       Date:  2021-11-26

3.  Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus.

Authors:  Elena G Bernea; Viorel I Suica; Elena Uyy; Aurel Cerveanu-Hogas; Raluca M Boteanu; Luminita Ivan; Iuliana Ceausu; Doina A Mihai; Constantin Ionescu-Tîrgoviște; Felicia Antohe
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

4.  Is there an association between platelet and blood inflammatory indices and the risk of gestational diabetes mellitus?

Authors:  Mahta Abbasi Fashami; Sepideh Hajian; Maryam Afrakhteh; Mehdi Khabaz Khoob
Journal:  Obstet Gynecol Sci       Date:  2020-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.